Cargando…
Endocannabinoids, endocannabinoid-like molecules and their precursors in human small intestinal lumen and plasma: does diet affect them?
PURPOSE: To determine the small intestinal concentration of endocannabinoids (ECs), N-acylethanolamines (NAEs) and their precursors N-acylphosphatidylethanolamines (NAPEs) in humans. To identify relationships between those concentrations and habitual diet composition as well as individual inflammato...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8137602/ https://www.ncbi.nlm.nih.gov/pubmed/33104865 http://dx.doi.org/10.1007/s00394-020-02398-8 |
_version_ | 1783695645164437504 |
---|---|
author | Tagliamonte, Silvia Gill, Chris I. R. Pourshahidi, L. Kirsty Slevin, Mary M. Price, Ruth K. Ferracane, Rosalia Lawther, Roger O’Connor, Gloria Vitaglione, Paola |
author_facet | Tagliamonte, Silvia Gill, Chris I. R. Pourshahidi, L. Kirsty Slevin, Mary M. Price, Ruth K. Ferracane, Rosalia Lawther, Roger O’Connor, Gloria Vitaglione, Paola |
author_sort | Tagliamonte, Silvia |
collection | PubMed |
description | PURPOSE: To determine the small intestinal concentration of endocannabinoids (ECs), N-acylethanolamines (NAEs) and their precursors N-acylphosphatidylethanolamines (NAPEs) in humans. To identify relationships between those concentrations and habitual diet composition as well as individual inflammatory status. METHODS: An observational study was performed involving 35 participants with an ileostomy (18W/17M, aged 18–70 years, BMI 17–40 kg/m(2)). Overnight fasting samples of ileal fluid and plasma were collected and ECs, NAEs and NAPEs concentrations were determined by LC-HRMS. Dietary data were estimated from self-reported 4-day food diaries. RESULTS: Regarding ECs, N-arachidonoylethanolamide (AEA) was not detected in ileal fluids while 2-arachidonoylglycerol (2-AG) was identified in samples from two participants with a maximum concentration of 129.3 µg/mL. In contrast, mean plasma concentration of AEA was 2.1 ± 0.06 ng/mL and 2-AG was 4.9 ± 1.05 ng/mL. NAEs concentrations were in the range 0.72–17.6 µg/mL in ileal fluids and 0.014–0.039 µg/mL in plasma. NAPEs concentrations were in the range 0.3–71.5 µg/mL in ileal fluids and 0.19–1.24 µg/mL in plasma being more abundant in participants with obesity than normal weight and overweight. Significant correlations between the concentrations of AEA, OEA and LEA in biological fluids with habitual energy or fat intakes were identified. Plasma PEA positively correlated with serum C-reactive protein. CONCLUSION: We quantified ECs, NAEs and NAPEs in the intestinal lumen. Fat and energy intake may influence plasma and intestinal concentrations of these compounds. The luminal concentrations reported would allow modulation of the homeostatic control of food intake via activation of GPR119 receptors located on the gastro-intestinal mucosa. CLINICAL TRIAL REGISTRY NUMBER AND WEBSITE: NCT04143139; www.clinicaltrials.gov. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00394-020-02398-8) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-8137602 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-81376022021-06-03 Endocannabinoids, endocannabinoid-like molecules and their precursors in human small intestinal lumen and plasma: does diet affect them? Tagliamonte, Silvia Gill, Chris I. R. Pourshahidi, L. Kirsty Slevin, Mary M. Price, Ruth K. Ferracane, Rosalia Lawther, Roger O’Connor, Gloria Vitaglione, Paola Eur J Nutr Original Contribution PURPOSE: To determine the small intestinal concentration of endocannabinoids (ECs), N-acylethanolamines (NAEs) and their precursors N-acylphosphatidylethanolamines (NAPEs) in humans. To identify relationships between those concentrations and habitual diet composition as well as individual inflammatory status. METHODS: An observational study was performed involving 35 participants with an ileostomy (18W/17M, aged 18–70 years, BMI 17–40 kg/m(2)). Overnight fasting samples of ileal fluid and plasma were collected and ECs, NAEs and NAPEs concentrations were determined by LC-HRMS. Dietary data were estimated from self-reported 4-day food diaries. RESULTS: Regarding ECs, N-arachidonoylethanolamide (AEA) was not detected in ileal fluids while 2-arachidonoylglycerol (2-AG) was identified in samples from two participants with a maximum concentration of 129.3 µg/mL. In contrast, mean plasma concentration of AEA was 2.1 ± 0.06 ng/mL and 2-AG was 4.9 ± 1.05 ng/mL. NAEs concentrations were in the range 0.72–17.6 µg/mL in ileal fluids and 0.014–0.039 µg/mL in plasma. NAPEs concentrations were in the range 0.3–71.5 µg/mL in ileal fluids and 0.19–1.24 µg/mL in plasma being more abundant in participants with obesity than normal weight and overweight. Significant correlations between the concentrations of AEA, OEA and LEA in biological fluids with habitual energy or fat intakes were identified. Plasma PEA positively correlated with serum C-reactive protein. CONCLUSION: We quantified ECs, NAEs and NAPEs in the intestinal lumen. Fat and energy intake may influence plasma and intestinal concentrations of these compounds. The luminal concentrations reported would allow modulation of the homeostatic control of food intake via activation of GPR119 receptors located on the gastro-intestinal mucosa. CLINICAL TRIAL REGISTRY NUMBER AND WEBSITE: NCT04143139; www.clinicaltrials.gov. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00394-020-02398-8) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2020-10-26 2021 /pmc/articles/PMC8137602/ /pubmed/33104865 http://dx.doi.org/10.1007/s00394-020-02398-8 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Contribution Tagliamonte, Silvia Gill, Chris I. R. Pourshahidi, L. Kirsty Slevin, Mary M. Price, Ruth K. Ferracane, Rosalia Lawther, Roger O’Connor, Gloria Vitaglione, Paola Endocannabinoids, endocannabinoid-like molecules and their precursors in human small intestinal lumen and plasma: does diet affect them? |
title | Endocannabinoids, endocannabinoid-like molecules and their precursors in human small intestinal lumen and plasma: does diet affect them? |
title_full | Endocannabinoids, endocannabinoid-like molecules and their precursors in human small intestinal lumen and plasma: does diet affect them? |
title_fullStr | Endocannabinoids, endocannabinoid-like molecules and their precursors in human small intestinal lumen and plasma: does diet affect them? |
title_full_unstemmed | Endocannabinoids, endocannabinoid-like molecules and their precursors in human small intestinal lumen and plasma: does diet affect them? |
title_short | Endocannabinoids, endocannabinoid-like molecules and their precursors in human small intestinal lumen and plasma: does diet affect them? |
title_sort | endocannabinoids, endocannabinoid-like molecules and their precursors in human small intestinal lumen and plasma: does diet affect them? |
topic | Original Contribution |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8137602/ https://www.ncbi.nlm.nih.gov/pubmed/33104865 http://dx.doi.org/10.1007/s00394-020-02398-8 |
work_keys_str_mv | AT tagliamontesilvia endocannabinoidsendocannabinoidlikemoleculesandtheirprecursorsinhumansmallintestinallumenandplasmadoesdietaffectthem AT gillchrisir endocannabinoidsendocannabinoidlikemoleculesandtheirprecursorsinhumansmallintestinallumenandplasmadoesdietaffectthem AT pourshahidilkirsty endocannabinoidsendocannabinoidlikemoleculesandtheirprecursorsinhumansmallintestinallumenandplasmadoesdietaffectthem AT slevinmarym endocannabinoidsendocannabinoidlikemoleculesandtheirprecursorsinhumansmallintestinallumenandplasmadoesdietaffectthem AT priceruthk endocannabinoidsendocannabinoidlikemoleculesandtheirprecursorsinhumansmallintestinallumenandplasmadoesdietaffectthem AT ferracanerosalia endocannabinoidsendocannabinoidlikemoleculesandtheirprecursorsinhumansmallintestinallumenandplasmadoesdietaffectthem AT lawtherroger endocannabinoidsendocannabinoidlikemoleculesandtheirprecursorsinhumansmallintestinallumenandplasmadoesdietaffectthem AT oconnorgloria endocannabinoidsendocannabinoidlikemoleculesandtheirprecursorsinhumansmallintestinallumenandplasmadoesdietaffectthem AT vitaglionepaola endocannabinoidsendocannabinoidlikemoleculesandtheirprecursorsinhumansmallintestinallumenandplasmadoesdietaffectthem |